Back
– Spin-out of Scorpion Therapeutics, led by former Scorpion Therapeutics management team – – Advancing multiple programs across cancer and other serious diseases; plans to advance first new product candidate into the clinic in 2026 – – Series A financing co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management, […]
